Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The **Fix protocol** is a multimodal postoperative pain management regimen developed and evaluated by **HaEmek Medical Center** in Israel. Specifically designed for women recovering from Cesarean section, the protocol involves the scheduled (fixed-interval) administration of three distinct analgesic agents: **tramadol**, **paracetamol** (acetaminophen), and **diclofenac**. This combination targets multiple pain pathways by utilizing a mu-opioid receptor agonist (tramadol), a central analgesic (paracetamol), and a non-steroidal anti-inflammatory drug (diclofenac). The protocol aims to maintain steady therapeutic levels of these medications during the first 48 hours post-surgery to provide consistent pain control, improve patient satisfaction, and reduce the need for rescue doses compared to on-demand administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tramadol + paracetamol + diclofenac.